Waiver from NZX Main Board Listing Rule 9.1.1

NZX Regulation Decision
Synlait Milk Limited (SML)
Application for a waiver from NZX Main Board Listing Rule
9.1.1







5 July 2018

NZX REGULATION DECISION – 5 July 2018 Page 2 of 5
Waiver from NZX Main Board Listing Rule 9.1.1
Decision
1. On the basis that the information provided by Synlait Milk Limited is complete and accurate
in all material respects, NZX Regulation (NZXR) grants SML a waiver from NZX Main
Board Listing Rule 9.1.1 to the extent that SML would be required to obtain shareholder
approval for SML Subsidiary to enter into the Variation.

2. The information on which this decision is based is set out in Appendix One to this decision.
This waiver will not apply if that information is not, or ceases to be, full and accurate in all
material respects.

3. The Rule to which this decision relates is set out in Appendix Two.

4. Capitalised terms that are not defined in this decision have the meanings given to them in
the Rules.

Reasons

5. In coming to the decision to provide the waiver set out in paragraph 1 above, NZXR has
considered that:

(a) the policy behind Rule 9.1.1 is to regulate those transactions which may change the
essential nature of an Issuer’s business or require the immediate expenditure of large
amounts of shareholders' funds. NZXR is comfortable that the granting of this waiver
does not offend the policy of this Rule;

(b) the Variation is entirely within the ordinary course of SML’s business, rather than
being a transaction that changes the essential nature of the business. The Variation
confirms and expands on the current commercial relationship between SML and
ATM, and provides some certainty to that existing commercial relationship, rather than
being an immediate expenditure of shareholder funds;

(c) the Variation provides a framework for orders with binding contracts only arising when
a member of the ATM group places or is deemed to place purchase orders. Therefore
there is limited accuracy in the estimation of the value of the Variation over the term
of the Supply Agreement.

(d) the Variation has been negotiated on an arm’s length basis, and is within the
competence and experience of the management and the directors of the SML group;
and

(e) there is precedent for the decision.

NZX REGULATION DECISION – 5 July 2018 Page 3 of 5
Appendix One
1. Synlait Milk Limited (SML) is a Listed Issuer with ordinary shares Quoted on the NZX Main
Board.

2. A wholly owned subsidiary of SML (SML Subsidiary), has entered into a variation (the
Variation) to an existing Nutritional Powders Manufacturing and Supply Agreement with a
wholly owned subsidiary (ATM Subsidiary) of The a2 Milk Company Limited (ATM) (the
Supply Agreement). The Variation is subject to SML and ATM obtaining a waiver from NZX
under Rule 9.1.1 or obtaining shareholder approval.

3. ATM is a Listed Issuer with ordinary shares Quoted on the NZX Main Board. ATM has
applied for an equivalent waiver from Rule 9.1.1 in relation to the Variation.

4. The Variation is intended to confirm the ongoing certainty of the current business
relationship between SML and ATM and to secure increased capacity. The Variation in itself
does not increase the volume of business between SML and ATM from current levels.

5. The key terms of the Variation can be summarised as:

(a) Term: the Variation will effectively extend the term of the Supply Agreement by 2
years and is terminable after July 2020 by either party giving at least three years’
notice to the other party. This effectively provides for a minimum term of 5 years;

(b) Minimum Supply Volume: SML Subsidiary is contractually bound to supply, under
purchase orders, up to a prescribed infant and pregnancy formula volume. The
Variation increases the volume that was previously provided for in the Supply
Agreement;

(c) Exclusivity: SML Subsidiary’s exclusive supply rights continue up to an increased
specified infant formula product volume in respect of infant formula already supplied
by SML for sale by the ATM group in the markets of China, Australia and New
Zealand.

(d) Sales Price: the sales price for products is not fixed in the contract and fluctuates
based on a variety of factors; and

(e) Minimum Purchase Amount: ATM Subsidiary will not be contractually bound to
place purchase orders for any minimum quantity.

(f) Adjustment of other terms reflecting the increase in the minimum supply
volume: the exclusivity, liability cap and insurance have increased taking into
account the increased volume.

6. On the basis that the Supply Agreement could remain in place for longer than the minimum
5 year term and that the exact volume of products to be purchased over the term of the
Supply Agreement is uncertain, there is potential for SML Subsidiary to sell product the value
of which could be in excess of 50% of the Average Market Capitalisation of SML.

NZX REGULATION DECISION – 5 July 2018 Page 4 of 5
7. SML has applied for a waiver from Rule 9.1.1 to enter into the Variation which may amount
to a series of related transactions with a value of greater than 50% of its average market
capitalisation. As at the date of this waiver, SML’s market capitalisation is approximately
$2.04 billion.

NZX REGULATION DECISION – 5 July 2018 Page 5 of 5
Appendix Two
Rule 9.1.1 Disposal or Acquisition of Assets

Rule 9.1.1 An Issuer shall not (subject to Rule 9.1.3) enter into any transaction or series of
linked or related transactions to acquire, sell, lease, exchange, or otherwise
dispose of (otherwise than by way of charge) assets of the Issuer or assets to be
held by the Issuer:

(a) which would change the essential nature of the business of the Issuer; or
(b) in respect of which the gross value is in excess of 50% of the Average
Market Capitalisation of the Issuer;

except with the prior approval of an Ordinary Resolution of the Issuer or a special
resolution if that Issuer must obtain approval of the transaction or transactions by
a special resolution under section 129 of the Companies Act 1993.